Natera envisions a future where personalized genetic insights fundamentally reshape healthcare, enabling earlier and more precise interventions that extend and enhance lives. By pioneering cell-free DNA testing and molecular diagnostics, we are driving a paradigm shift in disease detection, treatment, and monitoring across women’s health, oncology, and organ transplantation.
Through the integration of cutting-edge molecular biology, advanced bioinformatics, and artificial intelligence, we unlock the most detailed genomic information from a simple blood sample. This empowers clinicians and researchers worldwide with unparalleled accuracy and actionable insights, fostering a new era of preventive and personalized medicine.
We are committed to advancing the science and accessibility of genetic testing, partnering across the healthcare ecosystem to transform patient care and accelerate breakthroughs in disease understanding, drug development, and clinical outcomes.
Our Review
A Pioneer in Personalized Diagnostics
We've been watching Natera's evolution since their 2004 founding, and they've consistently impressed us with their innovative approach to genetic testing. What started as a focused prenatal testing company has grown into a powerhouse that's revolutionizing how we detect and monitor various health conditions.
Technology That's Changing Lives
What really catches our attention is Natera's cell-free DNA testing technology. It's like having a high-powered microscope that can spot genetic changes from just a simple blood draw. Their ability to detect changes at the single-molecule level isn't just clever science – it's transforming patient care in real, meaningful ways.
The company's product lineup is impressive: from Panorama for prenatal testing to Signatera for cancer monitoring, each solution addresses critical healthcare needs with remarkable precision. We're particularly intrigued by their Prospera test, which helps monitor organ transplant rejection without invasive biopsies.
Where Science Meets Scale
What sets Natera apart is their commitment to scientific validation. With over 300 peer-reviewed publications and multiple CAP-accredited, CLIA-certified labs, they're not just innovating – they're proving their methods work. This blend of cutting-edge technology and rigorous validation has earned them trust in the medical community.
Looking Ahead
While Natera isn't the only player in genetic testing, we believe they're positioned at the forefront of personalized medicine's future. Their continuous expansion into new areas like kidney disease research shows they're not resting on their laurels. For healthcare providers and patients seeking advanced diagnostic solutions, Natera offers some of the most sophisticated tools available in modern medicine.
Features
Cell-free DNA (cfDNA) testing technology
Non-invasive prenatal testing (Panorama™)
Tumor-informed circulating tumor DNA assay for cancer detection (Signatera™)
Donor-derived cfDNA test for transplant rejection assessment (Prospera™)
Genetic testing for kidney diseases with genomic and clinical data insights (Renasight™)
Jobs
FAQs
Ploy was founded in 2024.
Natera™ is a global leader in cell-free DNA and precision medicine, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard-of-care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are supported by more than 325 peer-reviewed publications that demonstrate excellent performance. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California, and through Foresight Diagnostics, its subsidiary, operates an ISO 27001-certified and CAP-accredited laboratory certified under CLIA in Boulder, Colorado. Please be advised that Natera will only reach out to candidates with an @natera.com email domain. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/
Infinity AI
Flowith
EchoTwin AI
Symbolica AI
Vital AI
